Intraurethral Alprostadil (MUSE): The Needle-Free Alternative

MUSE stands for Medicated Urethral System for Erection. After urinating — a wet urethra helps the pellet dissolve — a slim applicator places a small alprostadil pellet about three centimetres inside the urethra. The drug is absorbed through the urethral lining into the surrounding erectile tissue, where it relaxes smooth muscle in the same way an injection would.

Rolling the penis firmly between the hands for about ten seconds after insertion helps distribute the drug. An erection typically follows within five to ten minutes and lasts thirty to sixty minutes.

This is where expectations need managing. In the trials that supported approval, roughly 30–40% of men achieved intercourse — better than placebo by a clear margin, but well short of what injection therapy delivers. Absorption through the urethral lining is simply less efficient and less predictable than direct injection.

For that reason most urologists position MUSE as the option for men who genuinely will not inject. If the needle is not the obstacle, injection therapy is the stronger choice.

• Urethral burning or aching — reported by roughly a third of users and the leading reason for discontinuation.
• Minor bleeding or spotting from the urethra, usually from applicator technique.
• Dizziness, low blood pressure or fainting — uncommon but the reason the first dose should be supervised.
• Partner effects — some female partners report vaginal burning or irritation.
• Priapism — rarer than with injections, but the same four-hour emergency rule applies.

• Usually limited to two doses in 24 hours and no more than seven per week.
• Pellets require refrigeration; they can be kept at room temperature for a limited period — follow the packaging exactly.
• Per-dose cost is high relative to compounded injection therapy, and insurance coverage is inconsistent.
• Not suitable if you have a urethral stricture, balanitis, urethritis, or an abnormally positioned urethral opening.